Name
sibrotuzumab
Alternate Names
BIBH1
Abbreviations
BIBH-1
Category
Chemotherapy
Subcategory
Cytostatic agent--monoclonal antibody
NSC Number
None
Primary Site
Histology
None
Remarks
Phase I Monoclonal antibody with cytostatic properties. (human FAP (fibro-blast activation protein) Boehringer-Ingelheim Pharmaceuticals.
Coding
This drug should be coded